xovoltib 20mg tablet | Apple pharmaceuticals
Xovoltib 20mg
Description :
Xovoltib 20mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER.Xovoltib 20mg is a prescription drugs which is used under the guidance of medical practioners.
Indication :
Xovoltib 20mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body.Mechanism :
Xovoltib 20mg blocking the activating sites called tyrosine kinases of various proteins within the cell. These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. By stopping these targets, it will target the cancer will shrink.Side Effects :
Loss of appetite, Nausea , Vomiting, Diarrhoea, Mouth sores, Acne, Itchiness, Rash, Dryskin, Nail infection..

Drug Interaction :
Concomitant of Xovoltib 20mg with P-gp inhibitors (cyclosporine A, ketoconazole verapamil) will increase exposure to Afatinib
Interaction of Xovoltib 20mg with P-gpinducers (carbamazepine, phenytoin, phenobarbital) will decrease exposure to Afatinib.
Missed Dose :
If patient missed to take the dose of Xovoltib 20mg,the missed dose should be skipped and follow the regular dosing schedule. Do not self-medicate. Do not double the dose.
For More Information :
Mail to : applepharmaceutical@gmail.com
Solidnie napisane. Pozdrawiam i liczę na więcej ciekawych artykułów.
ReplyDelete